BTSG vs USPH
BTSG: An integrated, national home-based care provider delivering complementary pharmacy and clinical services to medically complex patients to reduce hospitalizations and lower costs. USPH: A roll-up platform consolidating fragmented outpatient physical therapy and occupational therapy clinics while building a B2B workplace injury prevention and ergonomics business serving Fortune 500 employers.
Side-by-side fundamentals
| Metric | BTSG | USPH | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $69.74 | $74.38 | |
| Market cap as of 2026-07-23 | $13.7B | $1.1B | |
| P/E as of 2026-07-23 | 44.17 | 32.79 | USPH lower |
| PEG as of 2026-07-23 | 1.97 | 8.89 | BTSG lower |
| Net margin as of 2026-07-23 | +2.3% | +4.4% | USPH higher |
| Gross margin as of 2026-07-23 | +12.2% | +19.0% | USPH higher |
| Operating margin as of 2026-07-23 | +2.7% | +10.0% | USPH higher |
| ROE as of 2026-07-23 | +16.7% | +7.1% | BTSG higher |
| ROA as of 2026-07-23 | +5.0% | +2.9% | BTSG higher |
| Debt / equity as of 2026-07-23 | 1.27 | 0.44 | USPH lower |
| Revenue growth (YoY) as of 2026-07-23 | +18.0% | +13.7% | BTSG higher |
| Revenue CAGR (3y) SEC XBRL | +18.7% | +12.2% | BTSG higher |
| Dividend yield as of 2026-07-23 | n/a | +2.5% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 1.84 | 1.13 | |
| 1-year return as of 2026-07-22 close | +246.1% | -0.9% | BTSG higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.